97229-11-3 (4-氯-2-甲磺酰基嘧啶,4-chloro-2-methanesulfonylpyrimidine)

CAS号:
97229-11-3
中文名称:
4-氯-2-甲磺酰基嘧啶
英文名称:
4-chloro-2-methanesulfonylpyrimidine
分子式:
C5H5ClN2O2S
分子量:
192.623398542404

4-氯-2-甲磺酰基嘧啶(97229-11-3)名称与标识符

名称

中文别名:
4-氯-2-甲磺酰基嘧啶;4-氯-2-(甲基磺酰基)嘧啶;
英文别名:
4-Chloro-2-(methylsulfonyl)pyrimidine;4-CHLORO-2-METHANESULFONYL-PYRIMIDINE;4-chloro-2-methylsulfonylpyrimidine;C5H5ClN2O2S;4-CHLORO-2-METHANESULFONYLPYRIMIDINE;PYRIMIDINE, 4-CHLORO-2-(METHYLSULFONYL)-;4-chloro-2-methylsulfonyl-pyrimidine;BWVZLXTZQHILRC-UHFFFAOYSA-N;FCH869011;4-chloro-2-methanesulphonylpyrimidine;2-(Methylsulfonyl)-4-chloropyrimidine;MB07468;SY017916;HC2105;4-Chloro-2-(methylsulfonyl)pyrimidine (ACI);97229-11-3;DB-010250;SCHEMBL758549;J-514903;Z1198221088;EN300-199073;CS-W004037;DTXSID70456893;AKOS005264720;MFCD09701372;DS-13870;

标识符

MDL:
MFCD09701372
InChIKey:
BWVZLXTZQHILRC-UHFFFAOYSA-N
Inchi:
1S/C5H5ClN2O2S/c1-11(9,10)5-7-3-2-4(6)8-5/h2-3H,1H3
SMILES:
O=S(C)(C1N=C(Cl)C=CN=1)=O

4-氯-2-甲磺酰基嘧啶(97229-11-3)物化性质

实验特性

  • LogP : 1.61430
  • PSA : 68.30000
  • 折射率 : 1.539
  • 沸点 : 371.1°C at 760 mmHg
  • 熔点 : 87-89 ºC
  • 蒸气压 : 0.1±0.5 mmHg at 25°C
  • 闪点 : 100.8±19.8 °C
  • 颜色与性状 : No data avaiable
  • 密度 : 1.486

计算特性

  • 精确分子量 : 191.97600
  • 氢键供体数量 : 0
  • 氢键受体数量 : 4
  • 可旋转化学键数量 : 1
  • 同位素质量 : 191.9760263g/mol
  • 重原子数量 : 11
  • 复杂度 : 223
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 0
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 0.7
  • 互变异构体数量 : 无
  • 表面电荷 : 0
  • 拓扑分子极性表面积 : 68.3

4-氯-2-甲磺酰基嘧啶(97229-11-3)海关数据

海关编码:
2933599090
海关数据:

中国海关编码:

2933599090

概述:

2933599090. 其他结构上有嘧啶环的化合物(包括其他结构上有哌嗪环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%

申报要素:

品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期

Summary:

2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

4-氯-2-甲磺酰基嘧啶(97229-11-3)推荐厂家 更多厂家(66)

4-氯-2-甲磺酰基嘧啶(97229-11-3)合成路线

合成路线:1 步
反应条件:
参考文献:
Synthesis of cytimidine through a one-pot copper-mediated amidation cascade
Serrano, Catherine M.; Looper, Ryan E., Organic Letters, 2011, 13(19), 5000-5003
合成路线:1 步
反应条件:
参考文献:
Chromium(VI) Oxide Catalyzed Oxidation of Sulfides to Sulfones with Periodic Acid
Xu, Liang; Cheng, Jie; Trudell, Mark L., Journal of Organic Chemistry, 2003, 68(13), 5388-5391
合成路线:1 步
反应条件:
参考文献:
Preparation of variolin B derivatives as antitumor agents
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Sulfone Displacement Approach for Large-Scale Synthesis of 4-Chloro-N-(1-methyl-1H-pyrazol-4-yl)pyrimidin-2-amine
Li, Chaomin ; Haeffner, Fredrik; Wang, Shujun; Yuan, Cuicui; Shang, Deju; et al, Organic Process Research & Development, 2022, 26(1), 137-143
合成路线:1 步
反应条件:
参考文献:
Aminopyrimidine compound used for inhibiting activity of protein kinase
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of aminopyrimidine compounds useful for the treatment of EGFR mutant kinase mediated diseases
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of indazole compounds that inhibit one or more receptor, or non-receptor, tyrosine or serine/threonine kinase
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Improved process for preparing lazertinib and intermediates thereof
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Design, synthesis, and activity of 2-imidazol-1-ylpyrimidine derived inducible nitric oxide synthase dimerization inhibitors
Davey, David D.; Adler, Marc; Arnaiz, Damian; Eagen, Keith; Erickson, Shawn; et al, Journal of Medicinal Chemistry, 2007, 50(6), 1146-1157
合成路线:1 步
反应条件:
参考文献:
Therapeutic compounds and methods of use thereof
, United States, , ,
合成路线:1 步
反应条件:
参考文献:
Systematically Mitigating the p38α Activity of Triazole-based BET Inhibitors
Carlson, Angela S. ; Cui, Huarui; Divakaran, Anand ; Johnson, Jorden A.; Brunner, Ryan M.; et al, ACS Medicinal Chemistry Letters, 2019, 10(9), 1296-1301
合成路线:1 步
反应条件:
参考文献:
Heterocyclic compounds for targeted degradation of RET and their preparation
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Novel in-vivo probe for real time longitudinal monitoring of inducible nitric-oxide synthase in living cells and animals
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of substituted 4-(1-pyrrolidinyl)pyrimidine compounds as dimerization inhibitors of neuronal nitric oxide synthase
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of fused pyrazole derivatives as P38 MAP kinase inhibitors
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
The synthesis and aminolysis of some 4-chloro-2-(substituted)thiopyrimidines
Hurst, Derek T.; Johnson, Matthew, Heterocycles, 1985, 23(3), 611-16
合成路线:1 步
参考文献:
Novel in-vivo probe for real time longitudinal monitoring of inducible nitric-oxide synthase in living cells and animals
, India, , ,
合成路线:1 步
参考文献:
Preparation heteroaryl pyrimidinylamine compounds and compositions for modulating EGFR mutant kinase activities
, United States, , ,
合成路线:1 步
参考文献:
Preparation of 2-[[(phenoxy)pyrimidinyloxy]phenyl]-3-methoxypropenoates as agrochemical fungicides
, European Patent Organization, , ,

4-氯-2-甲磺酰基嘧啶(97229-11-3)上下游